desipramine ( dmi ) can alter both the availability and receptor function of catecholamines , particularly ne : while both acute and chronic dmi treatments decrease ne reuptake , subsensitivity of beta-adrenergic receptors occurs only after chronic dmi treatment .
C0007412
catecholamines
C0028351
ne